The Latest Motrin Consumption Statistics Explained
29% of consumers in the United States used ibuprofen (brand name: Motrin) tablets in 2020.
The statistic “29% of consumers in the United States used ibuprofen (brand name: Motrin) tablets in 2020” indicates that nearly one-third of individuals in the U.S. reported using Motrin tablets as a form of pain relief or medication in the specific year mentioned. This data provides insight into the prevalence and popularity of ibuprofen usage among the general population in the United States during that time frame. It suggests that ibuprofen is a widely utilized over-the-counter medication for managing pain and inflammation, reflecting its perceived efficacy and accessibility among consumers. This statistic could be valuable for healthcare professionals, researchers, and pharmaceutical companies to better understand consumer behavior and preferences regarding pain relief products.
15.2% of American adults used ibuprofen (Motrin) in the past 30 days, according to a 2019 survey.
The statistic that 15.2% of American adults used ibuprofen (Motrin) in the past 30 days, according to a 2019 survey, indicates the prevalence of ibuprofen use among the adult population in the United States during that time period. This percentage suggests that a significant portion of adults relied on ibuprofen for pain relief, inflammation reduction, or fever management within the past month. The statistic provides insight into the commonality of ibuprofen usage and may be useful for healthcare professionals, researchers, and policymakers in understanding patterns of medication consumption and potential healthcare needs within the population.
Australia’s ibuprofen (Motrin) consumption per capita was 27 defined daily dose per 1,000 inhabitants per day in 2015.
The statistic indicates that in Australia in 2015, the average per capita consumption of ibuprofen (Motrin) was 27 defined daily doses per 1,000 inhabitants per day. This means that for every 1,000 people in the population, approximately 27 standard doses of ibuprofen were consumed daily on average. Defined daily dose (DDD) is a standardized measurement used in pharmacology to represent the typical dose of a drug used for its main indication in adults. A higher consumption of ibuprofen per capita suggests that it is a commonly used medication in Australia, and this information can be useful for healthcare policymakers, researchers, and healthcare providers in understanding patterns of medication use and potentially addressing any related health trends or issues.
Ibuprofen (Motrin) was one of the most commonly taken medications in a 2018 survey, coming in second place after paracetamol.
In a 2018 survey, ibuprofen (Motrin) emerged as one of the most widely consumed medications, ranking second only to paracetamol. This statistic suggests that ibuprofen is a popular choice among individuals seeking relief from pain or inflammation, reinforcing its widespread usage and accessibility in the market. The high ranking indicates that ibuprofen is a commonly relied upon medication by consumers for managing various health conditions. This finding highlights the significance of ibuprofen in the pharmaceutical landscape and underscores its popularity and relevance as an over-the-counter medication.
Ibuprofen, which includes Motrin, accounted for 41% of the total analgesics market in Brazil in 2018.
This statistic indicates that out of all the analgesic medications available in Brazil in 2018, Ibuprofen, which includes products like Motrin, held a significant portion of the market share at 41%. This suggests that Ibuprofen was a popular choice among consumers seeking pain relief in Brazil during that time. The high market share implies that Ibuprofen products were widely used and preferred over other types of analgesics available in the country. This information provides insight into the competitive landscape of the analgesics market in Brazil and highlights the dominance of Ibuprofen-containing products in meeting the pain relief needs of consumers.
In 2020, 6% of U.S. consumers used private label (generic) ibuprofen (includes Motrin) products.
The statistic indicates that in 2020, approximately 6% of consumers in the United States chose to purchase private label (generic) ibuprofen products, which includes brands like Motrin. This suggests that a small but notable portion of consumers opted for store-branded or non-branded ibuprofen instead of popular name brands. The preference for private label ibuprofen may stem from factors such as lower cost, perceived similarity in effectiveness to name brands, or availability in convenient store locations. Understanding the usage of private label ibuprofen products can provide insights into consumer behavior, preferences, and market trends within the over-the-counter medication industry.
Among U.S. adults aged 20 and over, 23.4% used ibuprofen (Motrin) products in the past 30 days from 2015 to 2018.
The statistic indicates that 23.4% of U.S. adults aged 20 and over reported using ibuprofen products such as Motrin in the past 30 days during the time period of 2015 to 2018. This suggests that a significant portion of the adult population in the United States relied on ibuprofen for pain relief or management over this four-year period. Ibuprofen is a commonly used over-the-counter medication for various types of pain and inflammation, so the high prevalence of its usage reflects its popularity among adults for addressing common health issues.
Ibuprofen was the second most widely used OTC analgesic among UK shoppers according to a 2019 Statista survey.
The statistic indicates that Ibuprofen ranked as the second most popular over-the-counter (OTC) analgesic among UK shoppers based on a survey conducted in 2019 by Statista. This suggests that amongst a range of pain relief options available without a prescription, Ibuprofen was prevalent and preferred by a significant number of consumers in the UK. The ranking implies that Ibuprofen likely holds a prominent position in the pain relief market, with many individuals opting to purchase this particular analgesic for their pain management needs.
In a 2018 study, the prevalence of self-reported NSAID (includes Motrin or Ibuprofen) use was 30.6%.
In the context of a 2018 study, the statistic indicating a prevalence of 30.6% of self-reported NSAID use, which includes common medications such as Motrin or Ibuprofen, means that nearly one-third of the study population reported using NSAIDs at some point. This statistic provides insight into the frequency and popularity of NSAID use among the study participants, highlighting the widespread use and potential impact of these medications. It suggests that NSAIDs are commonly utilized for various reasons, such as pain relief or anti-inflammatory purposes, and underscores the importance of monitoring and understanding the patterns of NSAID use for both healthcare providers and researchers.
The global sales for ibuprofen, including Motrin, are projected to reach $655.9 Million by 2026.
This statistic indicates that the total worldwide sales for ibuprofen, including the brand Motrin, are forecasted to increase to $655.9 million by the year 2026. This projection suggests a continued growth in the demand for ibuprofen-based products, likely influenced by factors such as an aging population, increasing prevalence of chronic pain conditions, and a rise in self-care practices. The significant market size underscores the widespread use and importance of ibuprofen as a common over-the-counter medication for pain relief and inflammation management.
References
0. – https://www.www.cdc.gov
1. – https://www.bmjopen.bmj.com
2. – https://www.www.statista.com
3. – https://www.www.grandviewresearch.com
